MDV3100-08: A phase I open-label, dose-escalation study evaluating the safety, tolerability, and pharmacokinetics of MDV3100 in women with incurable breast cancer Meeting Abstract

  

Authors:	Elias, A. D.; Richer, J. K.; LoRusso, P.; Peterson, A. C.; Steinberg, J. L.; Mordenti, J.; Lopez, C.; Hudis, C.; Traina, T. A.
Abstract Title:	MDV3100-08: A phase I open-label, dose-escalation study evaluating the safety, tolerability, and pharmacokinetics of MDV3100 in women with incurable breast cancer
Meeting Title:	48th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	30
Issue:	15 Suppl.
Meeting Dates:	2012 Jun 1-5
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2012-05-20
Language:	English
ACCESSION:	WOS:000318009800175
PROVIDER:	wos
DOI:	10.1200/jco.2012.30.15_suppl.TPS668
Notes:	Meeting Abstract: TPS668 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/152066